 Apyx Medical Corporation NASDAQ:APYX the Company, a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market, today announced that financial results for the second quarter of fiscal year 2020 will be released before the market opens on Monday, August 10. 